Evidence map›Paper›PMID 28759822›Full record

ReviewCancer treatment reviews2017

Treatment of late sequelae after radiotherapy for head and neck cancer.

Primož Strojan, Katherine A Hutcheson, Avraham Eisbruch, Jonathan J Beitler, Johannes A Langendijk, Anne W M Lee, June Corry, William M Mendenhall, Robert Smee, Alessandra Rinaldo and 1 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Cancer treatment reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed, 4 pooled it
17.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 4 syntheses or guidelines pooled it, 338 citations in OpenAlex.

  1. Pooled it
  2. Quality of life in nasopharyngeal carcinoma survivors: a systematic review and meta-analysis of longitudinal outcomes.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Adjuvant radiotherapy in pT3 glottic squamous cell carcinoma: an unnecessary burden?European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Review

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 7 countries.

Primož StrojanDepartment of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia. Electronic address: pstrojan@onko-i.si.
Katherine A HutchesonDepartment of Head and Neck Surgery, Section of Speech Pathology and Audiology, MD Anderson Cancer Center, Houston, TX, USA.
Avraham EisbruchDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Jonathan J BeitlerDepartments of Radiation Oncology, Otolaryngology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Johannes A LangendijkDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Anne W M LeeCenter of Clinical Oncology, University of Hong Kong - Shenzhen Hospital, Shenzhen, China.
June CorryRadiation Oncology, GenesisCare, St. Vincents's Hospital, Melbourne, Victoria, Australia.
William M MendenhallDepartment of Radiation Oncology, University of Florida, Gainesville, FL, USA.
Robert SmeeDepartment of Radiation Oncology, The Prince of Wales Cancer Centre, Sydney, NSW, Australia.
Alessandra RinaldoUniversity of Udine School of Medicine, Udine, Italy.
Alfio FerlitoCoordinator of the International Head and Neck Scientific Group, Italy.
Emory University · USInstitute of Oncology Ljubljana · SIPrince of Wales Hospital · AUSt Vincent's Hospital · AUThe University of Texas MD Anderson Cancer Center · USUniversity of Florida · USUniversity of Groningen · NLUniversity of Hong Kong - Shenzhen Hospital · CNUniversity of Michigan–Ann Arbor · USUniversity of Udine · IT

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

Radiotherapy (RT) is used to treat approximately 80% of patients with cancer of the head and neck. Despite enormous advances in RT planning and delivery, a significant number of patients will experience radiation-associated toxicities, especially those treated with concurrent systemic agents. Many effective management options are available for acute RT-associated toxicities, but treatment options are much more limited and of variable benefit among patients who develop late sequelae after RT. The adverse impact of developing late tissue damage in irradiated patients may range from bothersome symptoms that negatively affect their quality of life to severe life-threatening complications. In the region of the head and neck, among the most problematic late effects are impaired function of the salivary glands and swallowing apparatus. Other tissues and structures in the region may be at risk, depending mainly on the location of the irradiated tumor relative to the mandible and hearing apparatus. Here, we review the available evidence on the use of different therapeutic strategies to alleviate common late sequelae of RT in head and neck cancer patients, with a focus on the critical assessment of the treatment options for xerostomia, dysphagia, mandibular osteoradionecrosis, trismus, and hearing loss.

Indexed as

Deglutition DisordersDisease-Free SurvivalDose-Response Relationship, RadiationFemaleHead and Neck NeoplasmsHearing LossHumansMaleMandibleOsteonecrosisPrognosisRadiation InjuriesRadiation ToleranceRadiotherapyRadiotherapy DosageRisk AssessmentHead and neck cancerLate sequelaeRadiotherapyToxicityTreatment

Identifiers

PMID28759822
PMCPMC5902026
OpenAlexW2736411979

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.